Full Schedule

07:00 – 08:00 CST

Breakfast Session: Getting Funded

Location: Michigan A/B

Primary Presenter: – Department of Medicine, The Johns Hopkins University

07:00 – 08:00 CST

Breakfast Session: STI Testing Symposium

Location: Chicago 10

07:00 – 11:00 CST

Design-a-thon: Traveller Group

Location: Colorado

07:00 – 18:00 CST

Design-a-thon: Community Group

Location: Arkansas

07:00 – 18:00 CST

Design-a-thon: Early Career Research Group

Location: Mississippi

07:00 – 18:00 CST

Design-a-thon: Silver Group

Location: Ohio

08:30 – 09:30 CST

Plenary 3: Sexual Health during Social Disruption

Location: Sheraton Ballroom

Moderator:

Moderator: – The Leeds Teaching Hospitals NHS Trust

Invited Talk

08:30 – 09:00 CST

PL3.1 - STIs in criminalised populations

Location: Sheraton Ballroom

Invited Speaker:

Invited Talk

09:00 – 09:30 CST

PL3.2 - Refugee and migrant care

Location: Sheraton Ballroom

Invited Speaker: – Genitourinary Clinic, Mater Dei Hospital, Msida , Malta

Invited Talk

10:00 – 11:30 CST

Improving management of gonorrhea in times of increasing antimicrobial resistance

Location: Chicago 8

Moderator:

Moderator: – MDPH

10:00 – 10:15 CST

O7.1 - Within-person differences of N. gonorrhoeae antimicrobial resistance patterns between anatomical locations

Location: Chicago 8

Primary Presenter: – National Institute for Public Health and the Environment (RIVM)

Epidemiology & Monitoring

10:15 – 10:30 CST

O7.2 - Routine Pharyngeal Gonorrhea Test-of-Cure: Does It Detect Treatment Failures?

Location: Chicago 8

Primary Presenter: – U.S. Centers for Disease Control and Prevention

Clinical Science

10:30 – 10:45 CST

O7.3 - The impact of near-to-patient testing of sexually transmitted infections on clinical practice and antimicrobial stewardship: the NEPTUNE study

Location: Chicago 8

Primary Presenter: – Monash University and Melbourne Sexual Health Centre

Clinical Science

10:45 – 11:00 CST

O7.4 - Neisseria gonorrhoeae diagnostic escape from a gyrA-based test for ciprofloxacin susceptibility and the impact on zoliflodacin resistance

Location: Chicago 8

Primary Presenter: – Harvard School of Public Health

Basic & Translational Science

11:00 – 11:15 CST

O7.5 - Perceived benefits and implementation considerations for a novel lateral flow assay for the point-of-care detection of Neisseria gonorrhoeae in public healthcare facilities in South Africa

Location: Chicago 8

Primary Presenter: – Foundation for Professional Development

Implementation Science

11:15 – 11:30 CST

O7.6 - Resistance-minimizing strategies for introducing a novel antibiotic for gonorrhea treatment: a mathematical modeling study

Location: Chicago 8

Primary Presenter: – Harvard T.H. Chan School of Public Health

Co-Author: – Harvard T.H. Chan School of Public Health

Epidemiology & Monitoring

10:00 – 11:30 CST

The Future of STI Detection and Treatment: AI, Bots, and More!

Location: Chicago 9

Moderator:

Moderator: – HeHealth.ai

10:00 – 10:15 CST

O8.1 - Chatbot-Assisted Self-Assessment (CASA): Designing a novel AI-enabled sexual health intervention for racially minoritised communities

Location: Chicago 9

Primary Presenter: – University of Westminster, London

Behavioral & Social Science

10:15 – 10:30 CST

O8.2 - Artificial intelligence-assisted diagnostic tool for early detection of sexually transmitted infections

Location: Chicago 9

Primary Presenter: – Central Clinical School, Monash University

Epidemiology & Monitoring

10:30 – 10:45 CST

O8.3 - Adapting an Artificial Intelligence Sexually Transmitted Infections Screening Tool for Monkeypox Detection: The HeHealth Experience

Location: Chicago 9

Primary Presenter: – HeHealth.ai

Co-Author: – University of North Carolina at Chapel Hill

Epidemiology & Monitoring

10:45 – 11:00 CST

O8.4 - Health Information Exchange Enables Enhanced STI Surveillance Using Electronic Health Record Data

Location: Chicago 9

Primary Presenter: – Columbia University

Epidemiology & Monitoring

11:00 – 11:15 CST

O8.5 - Validation of an Easy to Administer Algorithm to Define Penicillin Allergy Status in STI Clinic Outpatients

Location: Chicago 9

Primary Presenter: – Louisiana State University Health Sciences Center, New Orleans

Clinical Science

11:15 – 11:30 CST

O8.6 - InSignia®: A molecular viability test for Chlamydia trachomatis and Neisseria gonorrhoeae

Location: Chicago 9

Primary Presenter: – SpeeDx Pty Ltd

Basic & Translational Science

10:00 – 11:30 CST

It’s worth a shot: the Science of stopping a global syphilis epidemic, one genome at a time

Location: Chicago 10

Moderator: – Johns Hopkins University School of Medicine

Moderator:

10:00 – 10:15 CST

O9.1 - The clinical and genomic diversity of Treponema pallidum among early syphilis patients enrolled in a global consortium for syphilis vaccine development

Location: Chicago 10

Primary Presenter: – Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA

Epidemiology & Monitoring

10:15 – 10:30 CST

O9.2 - Treponema pallidum Proteomic Analysis to Inform Syphilis Vaccine Development

Location: Chicago 10

Primary Presenter: – University of Victoria, Canada

Basic & Translational Science

10:30 – 10:45 CST

O9.3 - Syphilis and the Host; multi-omic analysis of host cellular responses to Treponema pallidum provides novel insight into syphilis pathogenesis

Location: Chicago 10

Primary Presenter: – University of Victoria, Canada

Basic & Translational Science

10:45 – 11:00 CST

O9.4 - Syphilis vaccine development: Generating a stable and efficacious multi-epitope vaccine chimera through protein engineering

Location: Chicago 10

Primary Presenter: – University of Victoria, Canada

Basic & Translational Science

11:00 – 11:15 CST

O9.5 - Persons with Early Syphilis Make Antibodies that Differentially Recognize Extracellular Loops of Treponema pallidum Outer Membrane Proteins

Location: Chicago 10

Primary Presenter: – Duke Human Vaccine Institute, Duke Univerity, Durham, North Carolina, USA

Basic & Translational Science

11:15 – 11:30 CST

O9.6 - Comparison of Treponema pallidum genomic sequences in clinical samples and rabbit passaged isolates from early syphilis patients in Guangzhou, China

Location: Chicago 10

Primary Presenter: – Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA

10:00 – 11:30 CST

Epidemic preparedness: Mpox and beyond

Location: Sheraton Ballroom

Moderator: – NHS Greater Glasgow and Clyde

Moderator:

Invited Talk

10:05 – 10:30 CST

SP3.1 - Mpox - state of the art clinical review

Location: Sheraton Ballroom

Invited Speaker: – Emory University School of Medicine

Invited Talk

10:30 – 10:55 CST

SP3.2 - Strengthening epidemic preparedenes

Location: Sheraton Ballroom

Invited Speaker: – University of Bern

Invited Talk

10:55 – 11:10 CST

SP3.3 - We Always Think It Is Not Going to Happen to Us - Personal Reflections on Mpox

Location: Sheraton Ballroom

Invited Speaker: – Positively UK

Invited Talk

10:00 – 11:30 CST

Novel strategies to optimise vaginal health

Location: Chicago 6

Moderator: – Division of Infectious Diseases, University of Alabama at Birmingham

Moderator: – Monash University and Melbourne Sexual Health Centre

Invited Talk

10:05 – 10:25 CST

SY5.1 - Menstrual Cups: A Potential Intervention for Preventing BV

Location: Chicago 6

Invited Speaker: – Rush University/University of Illinois Chicago

Invited Talk

10:25 – 10:45 CST

SY5.2 - Male Partner Treatment for Women with Bacterial Vaginosis

Location: Chicago 6

Invited Speaker: – Monash University and Melbourne Sexual Health Centre

Invited Talk

10:45 – 11:05 CST

SY5.3 - Vaginal microbiota transplant to promote Lactobacillus-dominant cervico-vaginal microbial communities

Location: Chicago 6

Invited Speaker: – Massachusetts General Hospital

Invited Talk

11:05 – 11:25 CST

SY5.4 - Advances in BV Biofilm Research and Investigational Treatments in this Area

Location: Chicago 6

Invited Speaker: – Minho University

Invited Talk

10:00 – 11:30 CST

Centering Equity, Inclusion and Diversity in STI/HIV Research

Location: Chicago 7

Moderator:

Invited Talk

10:05 – 10:20 CST

Why is it critical to center equity, inclusion, and diversity in STI research?

Location: Chicago 7

Invited Speaker: – CAAN Communities, Alliances & Neworks

Invited Talk

10:25 – 10:45 CST

SY6.2 - What are possible unintended consequences of research?

Location: Chicago 7

Invited Speaker: – Division of STD Prevention, Centers for Disease Control and Prevention

Invited Talk

10:45 – 11:05 CST

SY6.3 - Evidence based approaches to center equity, inclusion, and diversity

Location: Chicago 7

Invited Speaker: – WITS RHI

Invited Talk

11:05 – 11:25 CST

SY6.4 - Building trust in communities for STI prevention interventions

Location: Chicago 7

Invited Speaker: – University of Washington

Invited Talk

11:30 – 13:00 CST

Advocacy Zone

Location: Exhibit Hall

11:30 – 13:00 CST

Lunch Session: ASTDA Awards (Limited Lunch is only available to session attendees)

Location: Sheraton Ballroom

13:00 – 14:00 CST

Plenary 4: ASTDA Young Investigator

Location: Sheraton Ballroom

Primary Presenter: – The Johns Hopkins University

Primary Presenter: – University of Washington

Invited Talk

13:08 – 13:17 CST

YI1 - Feedbacks from HIV self-test users in Brazil: monitoring strategy and results

Location: Sheraton Ballroom

Primary Presenter: – Brazilian Ministry of Health

Implementation Science

13:18 – 13:22 CST

YI2 - Sexually Transmitted Infections Among Youth Exposed to Violence & Mental Health Outcomes in Zimbabwe

Location: Sheraton Ballroom

Primary Presenter: – Lewis University

Behavioral & Social Science

13:23 – 13:27 CST

YI3 - Development of a novel human oral tissue model of gonorrhoea

Location: Sheraton Ballroom

Primary Presenter: – University of Melbourne

Basic & Translational Science

13:28 – 13:37 CST

YI4 - A large-scale drug screen identifies novel therapeutics that target the syphilis pathogen Treponema pallidum

Location: Sheraton Ballroom

Primary Presenter: – Virginia Tech

Basic & Translational Science

13:38 – 13:42 CST

YI5 - Effect of antenatal Chlamydia trachomatis and Neisseria gonorrhoeae screening on post-delivery prevalence and vertical transmission in Gaborone, Botswana

Location: Sheraton Ballroom

Primary Presenter: – University of Edinburgh / Botswana Harvard Partnership

Epidemiology & Monitoring

13:43 – 13:47 CST

YI6 - Effect of antibiotic treatment on commensal Neisseria species load and presence in the oropharynx.

Location: Sheraton Ballroom

Primary Presenter: – Maastricht University Medical Center+

Basic & Translational Science

13:48 – 13:57 CST

YI7 - Predicting the Potential Impact of a Novel Chlamydia Vaccine in the United States

Location: Sheraton Ballroom

Primary Presenter: – Weill Cornell Medicine Qatar

Epidemiology & Monitoring

14:30 – 16:00 CST

Late Breaker 2: gonorrhoea and M. genitalium

Location: Michigan A/B

Moderator: – University of Washington

Moderator: – Harvard T.H. Chan School of Public Health

14:30 – 14:45 CST

LB2.1 - Evolving antimicrobial resistance in Mycoplasma genitalium: an updated global systematic review and meta-analysis

Location: Michigan A+B

Primary Presenter: – University of Melbourne

Epidemiology & Monitoring

14:45 – 15:00 CST

LB2.2 - Does screening for Neisseria gonorrhoeae and Chlamydia trachomatis affect the incidence of these infections in MSM taking HIV-PrEP? Results from a randomized, multicenter, controlled trial

Location: Michigan A+B

Primary Presenter: – Institute Of Tropical Medicine, Antwerp, Belgium

Clinical Science

15:00 – 15:15 CST

LB2.3 - High prevalence of STIs among men engaged in transactional sex and alcohol use in western Kenya: Important implications for STI intervention

Location: Michigan A+B

Primary Presenter: – RTI International

Behavioral & Social Science

15:15 – 15:30 CST

LB2.4 - Initial findings from increased gonorrhea culture surveillance in Massachusetts

Location: Michigan A+B

Primary Presenter: – Massachusetts Department of Public Health

Epidemiology & Monitoring

15:30 – 15:45 CST

LB2.5 - Detection of two ceftriaxone non-susceptible Neisseria gonorrhoeae isolates in an HIV pre-exposure prophylaxis program in Vietnam

Location: Michigan A+B

Primary Presenter: – Division of Infectious Diseases, UCLA School of Medicine

Epidemiology & Monitoring

15:45 – 16:00 CST

LB2.6 - Development of a Cas13a-based Point-of-Care Test for Neisseria gonorrhoeae Detection and Gyrase A Genotype Determination

Location: Michigan A+B

Primary Presenter: – Brigham and Women's Hospital

Basic & Translational Science

14:30 – 16:00 CST

STIs: a global health crisis, but not a lost cause

Location: Chicago 8

Moderator: – Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK

Moderator: – AHF-Mexico and AHF Global Public Health Institute

14:30 – 14:45 CST

O10.1 - What is the true global burden of sexually transmitted infections? What is and is not included in the Global Burden of Disease estimates

Location: Chicago 8

Primary Presenter: – University of Bern

Epidemiology & Monitoring

14:45 – 15:00 CST

O10.2 - STI epidemiology in the time of COVID-19 pandemic in European Union/European Economic Area (EU/EEA) countries– data artifact or real impact of the pandemic?

Location: Chicago 8

Primary Presenter: – European Centre for Diseases Prevention and Control (ECDC)

Epidemiology & Monitoring

15:00 – 15:15 CST

O10.3 - Gini coefficients for measuring the disparity in the distribution of HIV and sexually transmitted infections in both heterosexual and homosexual populations in Australia

Location: Chicago 8

Primary Presenter: – Central Clinical School, Monash University

Epidemiology & Monitoring

15:15 – 15:30 CST

O10.4 - Using a candidacy framework to investigate barriers and facilitators of a tailored HIV prevention and community based sexual and reproductive health intervention rural South Africa

Location: Chicago 8

Primary Presenter: – Africa Health Research Institute

Behavioral & Social Science

15:30 – 15:45 CST

O10.5 - Sexual and reproductive health among migrant peoples in transit through Darién, Panama: results from a rapid epidemiological study

Location: Chicago 8

Primary Presenter: – University of North Carolina at Greensboro & Center of Population Sciences for Health Equity, College of Nursing, Florida State University

Epidemiology & Monitoring

15:45 – 16:00 CST

O10.6 - Health Systems Response for Sexual and Reproductive Health Services During COVID-19: A Systematic Review and Global Crowdsourcing Open Call

Location: Chicago 8

Primary Presenter: – London School of Hygiene and Tropical Medicine

Implementation Science

14:30 – 16:00 CST

Gonorrhoea: epidemiology and vaccine

Location: Chicago 9

Moderator:

14:30 – 14:45 CST

O11.1 - Optimal gonorrhea control through vaccination and screening: a mathematical modeling and cost-effectiveness study

Location: Chicago 9

Primary Presenter: – Centers for Disease Control and Prevention

Behavioral & Social Science

14:45 – 15:00 CST

O11.2 - Global Surveillance for Antimicrobial Resistant Neisseria gonorrhoeae through the Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP), 2015-2022

Location: Chicago 9

Primary Presenter: – U.S. Centers for Disease Control and Prevention

Epidemiology & Monitoring

15:00 – 15:15 CST

O11.3 - Should we use the 4CMenB (Bexsero®) meningitis vaccine to protect men who have sex with men (MSM) in England against gonorrhoea? A model-based analysis of impact and cost-effectiveness.

Location: Chicago 9

Primary Presenter: – MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London

Epidemiology & Monitoring

15:15 – 15:30 CST

O11.4 - Characterisation of meningococcal vaccine-induced antibodies to Neisseria gonorrhoeae

Location: Chicago 9

Primary Presenter: – Institute for Glycomics, Griffith University

Basic & Translational Science

15:30 – 15:45 CST

O11.5 - Targeted metagenomic analysis shows distinct Neisseria gonorrhoeae strains at separate anatomical sites occur more commonly than mixed strain infections: implications for surveillance

Location: Chicago 9

Primary Presenter: – Maastricht University Medical Center+

Co-Author: – Maastricht University Medical Center+

Epidemiology & Monitoring

15:45 – 16:00 CST

O11.6 - Effect of oropharyngeal colonization with Neisseria meningitidis on subsequent risk of gonorrhea

Location: Chicago 9

Primary Presenter: – Ohio State University

Epidemiology & Monitoring

14:30 – 16:00 CST

Reducing stigma and improving care for sexual minorities and other vulnerable populations

Location: Chicago 10

Moderator: – Central Clinical School, Monash University

Moderator: – Family and Community Medicine Harm Reduction Research Lab College of Medicine-Tucson University of Arizona

14:30 – 14:45 CST

O12.1 - Inclusion that matters – Trans and gender diverse peoples’ perspectives on sexual health services in the United Kingdom

Location: Chicago 10

Primary Presenter: – Research Department of Primary Care and Population Health, University College London

Behavioral & Social Science

14:45 – 15:00 CST

O12.2 - Measuring and Reducing Enacted Healthcare Stigma for Sexual Minorities and People Living with HIV: An Incognito Patient Approach

Location: Chicago 10

Primary Presenter: – University of Minnesota

Behavioral & Social Science

15:00 – 15:15 CST

O12.3 - TXTXT Implementation Preparation: Identifying Contextual Barriers and Facilitators to HIV Medication Adherence Among Youth Across 12 Clinics Nationwide

Location: Chicago 10

Primary Presenter: – Ann and Robert H Lurie Children's Hospital

Implementation Science

15:15 – 15:30 CST

O12.4 - STI treatment and partner notification outcomes in pregnancy, South Africa

Location: Chicago 10

Primary Presenter: – Foundation for Professional Development

Implementation Science

15:30 – 15:45 CST

O12.5 - A Community-Based Participatory Research Project to Develop an Occupational Health and Safety Framework for Sex Workers

Location: Chicago 9

Primary Presenter: – University of Southern California

Co-Author: – University of North Carolina at Chapel Hill

Policy & Community Engagement

15:45 – 16:00 CST

O12.6 - Geosocial-Networking App Use Among Men Who Have Sex with Men in High HIV Community Viral Load Areas of Baltimore City

Location: Chicago 10

Primary Presenter: – Johns Hopkins School of Medicine

Behavioral & Social Science

14:30 – 16:00 CST

SP4 - Addressing the HIV and STI Syndemic: What Prevention Looks Like in 2023

Location: Sheraton Ballroom

Moderator: – Louisiana State University Health Sciences Center - New Orleans

Moderator: – University of Washington

Invited Talk

14:35 – 14:55 CST

SP4.1 - Improving the HIV PEP – PrEP interface

Location: Sheraton Ballroom

Invited Speaker: – MRC CTU at UCL

Invited Talk

14:55 – 15:15 CST

SP4.2 - STI biomedical prevention in 2023: Doxy PEP and Beyond

Location: Sheraton Ballroom

Invited Speaker: – University of Washington

Invited Talk

15:15 – 15:35 CST

SP4.3 - Integrating HIV and STI Research: Breaking down the Silos

Location: Sheraton Ballroom

Invited Speaker:

Invited Talk

14:30 – 16:00 CST

Emerging and Neglected STIs

Location: Chicago 6

Moderator: – Foundation for Professional Development

Moderator:

Invited Talk

14:35 – 14:55 CST

SY7.1 - Disseminated gonorrhoea - often overlooked

Location: Chicago 6

Invited Speaker:

Invited Talk

14:55 – 15:15 CST

SY7.2 - Has chancroid been eliminated in Africa?

Location: Chicago 6

Invited Speaker: – Institut Pasteur de Madagascar

Invited Talk

15:15 – 15:35 CST

SY7.3 - Emerging causes of urethritis

Location: Chicago 6

Invited Speaker: – Monash University and Melbourne Sexual Health Centre

Invited Talk

15:35 – 15:55 CST

SY7.4 - Understanding shigellosis in men who have sex with men

Location: Chicago 6

Invited Speaker: – UK Health Security Agency

Invited Talk

14:30 – 16:00 CST

Implementation to Scale

Location: Chicago 7

Moderator:

Moderator: – Tulane University School of Public Health and Tropical Medicine

Invited Talk

14:35 – 14:55 CST

SY8.1 - What can implementation science tell us about sustaining and scaling-up innovations?

Location: Chicago 7

Invited Speaker: – University of Oxford

Invited Talk

14:55 – 15:15 CST

SY8.2 - Should every successful intervention be scaled-up? The SHE clinic: an inclusive, locally-specific healthcare model for women who use drugs and exchange sex in Seattle, WA

Location: Chicago 7

Invited Speaker: – University of Washington

Invited Talk

15:15 – 15:35 CST

SY8.3 - Policy and clinical readiness analysis: barriers and facilitators to the integration of doxycycline post-exposure prophylaxis into Kenyan HIV PrEP programs

Location: Chicago 7

Invited Speaker: – Kenya Medical Research Institute

Invited Talk

15:35 – 15:55 CST

SY8.4 - Trickle Up HIV Care: Implementation for Health Equity

Location: Chicago 7

Invited Speaker: – The University of Chicago

Invited Talk

16:00 – 17:30 CST

Invite Only: GARDP

Location: Ontario

16:00 – 18:00 CST

Advocacy Zone

Location: Exhibit Hall

16:00 – 18:00 CST

Poster Session

Location: Riverwalk A/B

16:30 – 18:00 CST

Atlas of Queer Anatomy Workshop- Sign up Requested

Location: Erie

Invited Speaker: – Public Health Service Amsterdam and Amsterdam University Medical Centre